Overview

A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery

Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
This is a 16-day study to evaluate the safety and efficacy of ketorolac eye drops for the treatment of inflammation and pain associated with cataract surgery.
Phase:
Phase 3
Details
Lead Sponsor:
Allergan
Treatments:
Ketorolac
Ketorolac Tromethamine